FiercePharmaOriginal article
{"a":[{"_":"Sanofi asked to change Dupixent ads after Galderma challenge","$":{"href":"/marketing/sanofi-asked-change-dupixent-ads-after-galderma-challenge","hreflang":"en"}}]}
DupixentNegative
AI Analysis
Summary
Galderma Laboratories successfully challenged Sanofi's Dupixent advertising claims in a multi-case advertising row, forcing the French drugmaker to change or drop certain claims about its blockbuster medicine.
Outcome Details
Galderma successfully challenged Sanofi's Dupixent advertising claims, resulting in Sanofi being asked to change or drop certain claims
Importance:4/10
Sentiment:
-0.60
advertising disputeregulatory challengemarketing claimscompetitive litigation
Read the original article
Published by FiercePharma on August 6, 2026 7:42 AM